Pennsylvania 2025-2026 Regular Session

Pennsylvania Senate Bill SB347

Introduced
2/26/25  
Refer
2/26/25  
Engrossed
4/1/25  

Caption

Further providing for prohibited acts and penalties.

Impact

Should SB347 be enacted, it would enhance Pennsylvania's regulatory framework related to controlled substances. This amendment would empower county district attorneys and the state Attorney General to investigate and initiate criminal prosecutions for violations related to the operation of such clinics. This measure aims to strengthen law enforcement's ability to address concerns related to illicit drug use and trafficking, which are serious issues in many communities across the state.

Summary

Senate Bill 347, introduced to the Pennsylvania General Assembly, aims to amend the existing Controlled Substance, Drug, Device and Cosmetic Act. The bill specifically prohibits the operation of clinics or establishments that provide space for individuals to inject, ingest, or otherwise introduce controlled substances into their bodies unlawfully. It also outlines significant penalties for violations, categorizing them as felonies that may result in imprisonment of up to twenty years or substantial fines.

Sentiment

The sentiment surrounding SB347 reflects a push towards stricter enforcement of drug laws, particularly in response to the ongoing opioid crisis. Proponents of the bill likely view it as a necessary step to curb drug use and related criminal activity. However, potential opponents might argue that this measure could disproportionately impact vulnerable populations who rely on such spaces for harm reduction, raising ethical considerations about the approach to drug policy.

Contention

A notable point of contention revolves around the balance between public safety and harm reduction strategies. Some advocates for drug policy reform may argue that while the intention of SB347 is to combat drug abuse, the methods proposed could lead to increased criminalization of individuals struggling with addiction, rather than addressing the root causes. This debate highlights the complex nature of drug legislation and the need for thoughtful solutions that consider both enforcement and health-based approaches.

Companion Bills

No companion bills found.

Previously Filed As

PA HB377

Further providing for prohibited acts and penalties.

PA HB622

Further providing for prohibited acts and penalties.

PA HB758

Further providing for prohibited acts and penalties.

PA SB75

Further providing for prohibited acts and penalties.

PA HB809

Further providing for definitions and for prohibited acts and penalties; and providing for syringe service programs authorized.

PA HB306

Further providing for definitions, for prohibition and for penalties.

PA HB57

In other offenses, further providing for drug trafficking sentencing and penalties.

PA SB1005

Further providing for definitions and for refusal to provide property prohibited, providing for refusal to accept cash payment and further providing for injunctive relief, for civil penalties and for private actions.

PA SB405

Further providing for definitions.

PA SB628

Further providing for definitions and for misbranding.

Similar Bills

No similar bills found.